Aurobindo arm Lannett’s facility in U.S. gets 4 U.S. FDA observations
Lannett’s Seymour manufacturing facility has the capacity to scale production to approximately 4 billion doses annually.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.thehindu.com — the content belongs to The Hindu.
